MGMT promoter hypermethylation correlates with a survival...

European Journal of Cancer 2009 Vol. 45; Iss. 1

MGMT promoter hypermethylation correlates with a survival benefit from temozolomide in patients with recurrent anaplastic astrocytoma but not glioblastoma

J. Sadones, A. Michotte, P. Veld, C. Chaskis, R. Sciot, J. Menten, E.J.R. Joossens, T. Strauven, L.A. D’Hondt, D. Sartenaer, S.F.E.H. Califice, K. Bierau, C. Svensson, J. De Grève, B. Neyns
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
45
Year:
2009
Language:
english
Pages:
154
DOI:
10.1016/j.ejca.2008.09.002
File:
PDF, 153 KB
english, 2009
Conversion to is in progress
Conversion to is failed